Human NK cell recognition of target cells in the prism of natural cytotoxicity receptors and their ligands

Journal of Immunotoxicology

Volumn 9, Issue 3, 2012, Pages 267-274

  Brusilovsky, Michael ^a   Rosental, Benyamin ^a   Shemesh, Avishai ^a   Appel, Michael Y ^a   Porgador, Angel ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Cancer; Ligand; Natural Cytotoxicity Receptor (NCR); Natural Killer (NK) cells; receptors; Viral infection; Virus

Indexed keywords

LIGAND; NATURAL CYTOTOXICITY RECEPTOR; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL INTERACTION; CYTOTOXICITY; ECTROMELIA VIRUS; HUMAN; MEMBRANE BIOLOGY; MOLECULAR PATHOLOGY; NATURAL KILLER CELL; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; VACCINIA VIRUS;

ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, VIRAL; HUMANS; KILLER CELLS, NATURAL; LIGANDS; MICE; NEOPLASMS; RECEPTORS, NATURAL CYTOTOXICITY TRIGGERING;

EID: 84865312352     PISSN: 1547691X     EISSN: None     Source Type: Journal    
DOI: 10.3109/1547691X.2012.675366     Document Type: Article

References (63)

1. Achdout, H., Meningher, T., Hirsh, S., Glasner, A., Bar-On, Y., Gur, C., Porgador, A., Mendelson, M., Mandelboim, M., and Mandelboim, O. 2010. Killing of avian and Swine infuenza virus by natural killer cells. J. Virol. 84:3993-4001.
2. Arnon, T. I., Achdout, H., Levi, O., Markel, G., Saleh, N., Katz, G., Gazit, R., Gonen-Gross, T., Hanna, J., Nahari, E., Porgador, A., Honigman, A., Plachter, B., Mevorach, D., Wolf, D. G., and Mandelboim, O. 2005. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat. Immunol. 6:515-523. (Pubitemid 41716765)
3. Arnon, T. I., Achdout, H., Lieberman, N., Gazit, R., Gonen-Gross, T., Katz, G., Bar-Ilan, A., Bloushtain, N., Lev, M., Joseph, A., Kedar, E., Porgador, A., and Mandelboim, O. 2004. Te mechanisms controlling the recognition of tumor-and virus-infected cells by NKp46. Blood 103:664-672. (Pubitemid 38140102)
4. Arnon, T. I., Lev, M., Katz, G., Chernobrov, Y., Porgador, A., and Mandelboim, O. 2001. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur. J. Immunol. 31:2680-2689. (Pubitemid 32898735)
5. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., and Spies, T. 1999. Activation of NK cells and T-cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727-729.
6. Blackhall, F. H., Merry, C. L., Davies, E. J., and Jayson, G. C. 2001. Heparan sulfate proteo-glycans and cancer. Br. J. Cancer 85:1094-1098.
7. Bloushtain, N., Qimron, U., Bar-Ilan, A., Hershkovitz, O., Gazit, R., Fima, E., Korc, M., Vlodavsky, I., Bovin, N. V., and Porgador, A. 2004. Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46. J. Immunol. 173:2392-2401. (Pubitemid 39063095)
8. Brandt, C. S., Baratin, M., Yi, E. C., Kennedy, J., Gao, Z., Fox, B., Haldeman, B., Ostrander, C. D., Kaifu, T., Chabannon, C., Moretta, A., West, R., Xu, W., Vivier, E., and Levin, S. D. 2009. Te B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J. Exp. Med. 206:1495-1503.
9. Campbell, K. S., Dessing, M., Lopez-Botet, M., Cella, M., and Colonna, M. 1996. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J. Exp. Med. 184:93-100. (Pubitemid 26247218)
10. Cantoni, C., Bottino, C., Vitale, M., Pessino, A., Augugliaro, R., Malaspina, A., Parolini, S., Moretta, L., Moretta, A., and Biassoni, R. 1999. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immuno-globulin superfamily. J. Exp. Med. 189: 787-796.
11. Chang, C., Dietrich, J., Harpur, A. G., Lindquist, J. A., Haude, A., Loke, Y. W., King, A., Colonna, M., Trowsdale, J., and Wilson, M. J. 1999. Cutting edge: KAP10, a novel trans-membrane adapter protein genetically linked to DAP12 but with unique signaling properties. J. Immunol. 163:4651-4654. (Pubitemid 29501224)
12. Chisholm, S. E., and Reyburn, H. T. 2006. Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors. J.Virol. 80:2225-2233. (Pubitemid 43271529)
13. Costello, R. T., Sivori, S., Marcenaro, E., Lafage-Pochitalof, M., Mozziconacci, M. J., Reviron, D., Gastaut, J. A., Pende, D., Olive, D., and Moretta, A. 2002. Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 99:3661-3667. (Pubitemid 34534536)
14. Dennissen, M. A., Jenniskens, G. J., Piefers, M., Versteeg, E. M., Petitou, M., Veerkamp, J. H., and van Kuppevelt, T. H. 2002. Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies. J. Biol. Chem. 277:10982-10986. (Pubitemid 34952854)
15. de Paz, J. L., Moseman, E. A., Noti, C., Polito, L., vonAndrian, U. H., and Seeberger, P. H. 2007. Profling heparin-chemokine interactions using synthetic tools. ACS Chem. Biol. 2: 735-744. (Pubitemid 350285909)
16. Diefenbach, A., Jensen, E. R., Jamieson, A. M., and Raulet, D. H. 2001. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413:165-171. (Pubitemid 32867877)
17. Draghi, M., Pashine, A., Sanjanwala, B., Gendzekhadze, K., Cantoni, C., Cosman, D., Moretta, A., Valliante, N. M., and Parham, P. 2007. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to infuenza infection. J. Immunol. 178:2688-2698. (Pubitemid 46333145)
18. Esin, S., Batoni, G., Counoupas, C., Stringaro, A., Brancatisano, F. L., Colone, M., Maisetta, G., Florio, W., Arancia, G., and Campa, M. 2008. Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria. Infect. Immun. 76:1719-1727. (Pubitemid 351562017)
19. Esko, J. D., and Lindahl, U. 2001. Molecular diversity of heparan sulfate. J. Clin. Invest. 108:169-173. (Pubitemid 32656238)
20. Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M., and Munz, C. 2002. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195:343-351. (Pubitemid 34461492)
21. Garcia-Iglesias, T., del Toro-Arreola, A., Albarran-Somoza, B., del Toro-Arreola, S., Sanchez-Hernandez, P. E., Ramirez-Duenas, M. G., Balderas-Pena, L. M., Bravo-Cuellar, A., Ortiz-Lazareno, P. C., and Daneri-Navarro, A. 2009. Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions. BMC Cancer 9:186.
22. Garg, A., Barnes, P. F., Porgador, A., Roy, S., Wu, S., Nanda, J. S., Grifth, D. E., Girard, W. M., Rawal, N., Shetty, S., and Vankayalapati, R. 2006. Vimentin expressed on Mycobac-terium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor. J. Immunol. 177:6192-6198. (Pubitemid 44628837)
23. Gur, C., Porgador, A., Elboim, M., Gazit, R., Mizrahi, S., Stern-Ginossar, N., Achdout, H., Ghadially, H., Dor, Y., Nir, T., Doviner, V., Hershkovitz, O., Mendelson, M., Naparstek, Y. and Mandelboim, O. 2010. Te activating receptor NKp46 is essential for the development of Type 1 diabetes. Nat. Immunol. 11:121-128.
24. Hecht, M. L., Rosental, B., Horlacher, T., Hershkovitz, O., de Paz, J. L., Noti, C., Schauer, S., Porgador, A., and Seeberger, P. H. 2009. Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to diferent heparan sulfate/heparin sequences. J. Proteome Res. 8:712-720.
25. Hershkovitz, O., Jarahian, M., Zilka, A., Bar-Ilan, A., Landau, G., Jivov, S., Tekoah, Y., Glicklis, R., Gallagher, J. T., Hoffmann, S.C., Zer, H., Mandelboim, O., Watzl, C., Momburg, F., and Porgador, A. 2008a. Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: A lesson for the use of recombinant immunoreceptors as an immunological tool. Glycobiology 18:28-41.
26. Hershkovitz, O., Jivov, S., Bloushtain, N., Zilka, A., Andau, G., Bar-Ilan, A., Lichtenstein, R. G., Campbell, K. S., van Kuppevelt, T. H., and Porgador, A. 2007. Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44. Biochemistry 46:7426-7436. (Pubitemid 46986369)
27. Hershkovitz, O., Rosental, B., Rosenberg, L. A., Navarro-Sanchez, M. E., Jivov, S., Zilka, A., Gershoni-Yahalom, O., Brient-Litzler, E., Bedouelle, H., HO, J. W., Campbell, K. S., Rager-Zisman, B., Despres, P., and Porgador, A. 2009. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J. Immunol. 183:2610-2621
28. Hershkovitz, O., Zilka, A., Bar-Ilan, A., Abutbul, S., Davidson, A., Mazzon, M., Kummerer, B. M., Monsoengo, A., Jacobs, M., and Porgador, A. 2008b. Dengue virus replicon expressing the nonstructural proteins sufces to enhance membrane expression of HLA Class I and inhibit lysis by human NK cells. J. Virol. 82:7666-7676. (Pubitemid 352031232)
29. Ho, J. W., Hershkovitz, O., Peiris, M., Zilka, A., Bar-Ilan, A., Nal, B., Chu, K., Kudelko, M., Kam, Y. W., Achdout, H., Mandelboim, M., Altmeyer, R., Mandelboim, O., Bruzzone, R., and Porgador, A. 2008. H5-type infuenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44. J. Virol. 82:2028-2202.
30. Ito, K., Higai, K., Sakurai, M., Shinooda, C., Yanai, K., Azume, Y., and Matsumoto, K. 2011. Binding of natural cytotoxicity receptor NKp46 to sulfate-and α2, 3-NeuAc-containing glycans and its mutagenesis. Biochem. Biophys. Res. Commun. 406:377-382.
31. Jarahian, M., Fiedler, M., Cohnen, A., Djandji, D., Hammerling, G. J., Gati, C., Cerwenka, A., Turner, P. C., Moyer, R. W., Watzl, C., Hengel, H., and Momburg, F. 2011. Modulation of NKp30-and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. PLoS Pathog. 7:e1002195.
32. Jarahian, M., Watzl, C., Fournier, P., Arnold, A., Djandji, D., Zahedi, S., Cerwenka, A., Paschen, A., Schirrmacher, V., and Momburg, F. 2009. Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase. J. Virol. 83:8108-8121.
33. Jayson, G. C., Lyon, M., Paraskeva, C., Turnbull, J. E., Deakin, J. A., and Gallagher, J. T. 1998. Heparan sulfate undergoes specifc structural changes during the progression from human colon adenoma to carcinoma in vitro. J. Biol. Chem. 273:51-57. (Pubitemid 28042175)
34. Kelly, J. M., Darcy, P. K., Markby, J. L., Godfrey, D. I., Takeda, K., Tagita, H., and Smyth, M. J. 2002. Induction of tumor-specifc T cell memory by NK cell-mediated tumor rejection. Nat. Immunol. 3:83-90. (Pubitemid 34065622)
35. Lodoen, M. B., and Lanier, L. L. 2006. Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol. 18:391-398. (Pubitemid 43947576)
36. Macfarlane, A. W., and Campbell, K. S. 2006. Signal transduction in natural killer cells. Curr Top. Microbiol. Immunol. 298:23-57.
37. Magri, G., Muntasell, A., Romo, N., Saez-Borderias, A., Pende, D., Geraghty, D. E., Hengel, H., Angulo, A., Moretta, A., and LopezBotet, M. 2011. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 117:848-856.
38. Mandelboim, O., and Porgador, A. 2001. NKp46. Int. J. Biochem. Cell. Biol. 33:1147-1150. (Pubitemid 32972199)
39. Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Arnon, T. I., Bushkin, Y., Davis, D. M., Strominger, J. L., Yewdell, J. W., and Porgador, A. 2001. Recognition of hemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409:1055-1060. (Pubitemid 32204059)
40. Mao, H., Tu, W., Liu, Y., Qin, G., Zheng, J., Chan, P. L., Lam, K. T., Peiris, J. S., and LauY. L., 2010. Inhibition of human natural killer cell activity by infuenza virions and hemagglutinin. J. Virol. 84:4148-4157.
41. Matzinger, P. 2002. Te danger model: A renewed sense of self. Science 296:301-305. (Pubitemid 34303674)
42. Mavoungou, E., Held, J., Mewono, L., and Kremsner, P. G. 2007. A Dufy binding-like domain is involved in the NKp30-mediated recognition of Plasmodium falciparum-parasitized erythrocytes by natural killer cells. J. Infect. Dis. 195:1521-1531. (Pubitemid 46717471)
43. Mendelson, M., Tekoah, Y., Zilka, A., Gershoni-Yahalom, O., Gazit, R., Achdout, H., Bovin, N. V., Meningher, T., Mandelboim, M., Mandelboim, O., David, A., and Porgador, A. 2010. NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin Type 1 of infuenza virus. J. Virol. 84: 3789-3797.
44. Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., and Moretta, L. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197-223. (Pubitemid 32368034)
45. Owen, R. E., Yamada, E., Tompson, C. I., Phillipson, L. J., Tompson, C., Taylor, E., Zambon, M., Osborn, H. M., Barclay, W. S., and Borrow, P. 2007. Alterations in receptor binding properties of recent human infuenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells. J. Virol. 81:11170-11178. (Pubitemid 47536089)
46. Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., Bottino, C., Moretta, L., and Moretta, A. 1999. Identifcation and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 190:1505-1516.
47. Perussia, B., and Loza, M. J. 2003. Linear "2-0-1" lymphocyte development: Hypotheses on cellular bases for immunity. Trends Immunol. 24:235-241. (Pubitemid 36555961)
48. Pessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, L., Biassoni, R., and Moretta, A. 1998. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. Med. 188:953-960. (Pubitemid 28433421)
49. Platonova, S., Cherfls-Vicini, J., Damotte, D., Crozet, L., Vieillard, V., Validire, P., Andre, P., Dieu-Nosjean, M. C., Alifano, M., Regnard, J. F., Fridman, W. H., Sautes-Fridman, C., and Cremer, I. 2011. Profound coordinated alterations of intra-tumoral NK cell phenotype and function in lung carcinoma. Cancer Res. 71:5412-5422.
50. PoggevonStrandmann, E., Simhadri, V. R., von Tresckow, B., Sasse, S., Reiners, K. S., Hansen, H. P., Rothe, A., Boll, B., Simhadri, V. L., Borchmann, P., McKinnon, P. J., Hallek, M., and Engert, A. 2007. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity. 27:965-974. (Pubitemid 350251218)
51. Porgador, A. 2005. Natural cytotoxicity receptors: Pattern recognition and involvement of carbohydrates. Scientifc World Journal 5:151-154.
52. Romo, N., Magri, G., Muntasell, A., Heredia, G., Baia, D., Angulo, A., Guma, M., and Lopez-Botet, M. 2011. Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization. J. Leukocyte Biol. 90:717-726.
53. Rosental, B., Brusilovsky, M., Hadad, U., Oz, D., Appel, M. Y., Afergan, F., Yossef, R., Rosenberg, L. A., Aharoni, A., Cerwenka, A., Campbell, K. S., Braiman, A., and Porgador, A. 2011. Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44. J. Immunol. 187:5693-5702.
54. Sanderson, R. D., Yang, Y., Kelly, T., Macleod, V., Dai, Y., and Teus, A. 2005. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: Growth regulation and the prospect of new cancer therapies. J. Cell Biochem. 96:897-905. (Pubitemid 41688716)
55. Sasisekharan, R., and Venkataraman, G. 2000. Heparin and heparan sulfate: Biosynthesis, structure and function. Curr. Opin. Chem. Biol. 4:626-631.
56. Simhadri, V. R., Reiners, K. S., Hansen, H. P., Topolar, D., Simhadri, V. L., Nohroudi, K., Kufer, T. A., Engert, A., and Pogge von Strandmann, E. 2008. Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function. PLoS One 3:e3377.
57. Sivori, S., Vitale, M., Morelli, L., Sanseverino, L., Augugliaro, R., Bottino, C., Moretta, L., and Moretta, A. 1997. p46, a novel natural killer cell-specifc surface molecule that mediates cell activation. J. Exp. Med. 186:1129-1136. (Pubitemid 27441156)
58. Smetsers, T. F., van de Westerlo, E. M., ten Dam, G. B., Clarijs, R., Versteeg, E. M., van Geloof, W. L., Veerkamp, J. H., van Muijen, G. N., and van Kuppevelt, T. H. 2003. Localization and characterization of melanoma-associated glycosaminoglycans: Differential expression of chondroitin and heparan sulfate epitopes in melanoma. Cancer Res. 63:2965-2970. (Pubitemid 36667170)
59. Stoimenov, I., and Helleday, T. 2009. PCNA on the crossroad of cancer. Biochem. Soc. Trans. 37:605-613.
60. Vankayalapati, R., Wizel, B., Weis, S. E., Saf, H., Lakey, D. L., Mandelboim, O., Samten, B., Porgador, A., and Barnes, P. F. 2002. Te NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 168:3451-3457. (Pubitemid 34250410)
61. + T-cells during HIV-1 infection: A gp41 peptide induces the expression of an NKp44 ligand. Proc. Natl. Acad. Sci. USA 102:10981-10986. (Pubitemid 41105979)
62. Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., and Moretta, A. 1998. NKp44, a novel triggering surface molecule specifcally expressed by activated natural killer cells, is involved in nonmajor histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187:2065-2072. (Pubitemid 28285576)
63. Yusa, S., and CampbellK. S., 2003. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells. J. Immunol. 170: 4539-4547. (Pubitemid 36519959)